FOIA to National Institute of Allergy and Infectious Diseases seeking emails from the White House “Covid Mail” internal email system, which reportedly is used to forward requests from “friends and family” of the White House to agency officials.

Trump has seemingly failed to learn that no amount of political spin can minimize his administration’s mismanaged pandemic response.

With three lawsuits and more than 400 public records requests filed, American Oversight intends to get to the bottom of what has been happening behind the scenes in the Trump administration’s mismanaged pandemic response.

American Oversight's lawsuit against the Department of Health and Human Services, the Food and Drug Administration, the National Institute of Allergy and Infectious Diseases, and the Centers for Medicare and Medicaid Services for email communications between agency and White House officials involved in the federal government’s coronavirus response, and any directives, orders, or guidance from HHS or the White House regarding public communications or press strategy.

FOIA to National Institute of Allergy and Infectious Diseases seeking communications with companies developing vaccines or treatments for coronavirus.

FOIA to National Institute of Allergy and Infectious Diseases seeking communications with individuals regarding vaccines or treatments for coronavirus.

It shouldn’t be surprising that the president, who downplayed the crisis until just a few weeks ago, is once again avoiding taking responsibility.

FOIA request to the National Institute of Allergy and Infectious Disease (NIAID) seeking any directive, order, or guidance requiring or advising Dr. Anthony Fauci to cancel or decline media appearances, or directing him to convey specific messages or content during media appearances.

FOIA to the National Institute of Allergy and Infectious Diseases (NIAID) seeking communications with companies developing vaccines or treatments for coronavirus.

FOIA to the National Institute of Allergy and Infectious Diseases seeking communications regarding companies developing vaccines or treatments for coronavirus.